Rise and shine. Another glorious day is unfolding here on the Pharmalot corporate campus, where we are moving along like a cool breeze. Of course, there is much to be done - phone calls, meetings, reading documents. You name it. And we know you can related. So grab that cup of stimulation - no excuses, please - and pick up your to-do list. Meanwhile, here are some tidbits from around your world. Have a good one...
US Court Orders Seizure Of Cipla Pet Drug For Patent Violation (Dow Jones)
Lilly Plans 10 Drug In Final-Stage Trials By End Of 2011 (Bloomberg News)
Niaspan Prescriptions Fall After Negative Study Results (Dow Jones)
Pfizer Signs Deal With Russian Venture Capital Firm For R&D (Associated Press)
Forest Files COPD Drug For FDA Approval (Pharma Times)
'Neurontin Killed Our Husbands' (AOL Healthy Living)
Lundbeck Will Not Pull Drug Used In US Executions (Reuters)
Canadians Wait 30 Months To Access New Drugs: Study (Pharma Times)
EDITOR’S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr
1 Comment
Lechleiter is blowing smoke. Here's the real Lilly pipeline, mostly line extensions. No where near able to scale back up the patent cliff.
http://www.lilly.com/SiteCollectionDocuments/FlashFiles/Pipeline/Clinical%20Development%20Pipeline/index.html#PhaseIII